FABP5 and breast carcinoma: Research by Ju et al. (2018) also supports the same hypothesis, as the study reported that 4-Amino-2-trifluoromethyl-phenyl retinate (ATPR) is an E-FABP inhibitor, and the inhibitory effect shows a decrease in breast cancer proliferation by inducing cell differentiation.